U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Sold by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans lowered its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH – Get Rating) by 6.5% in the fourth quarter, HoldingsChannel reports. The fund owned 17,095 shares of the company’s stock after selling 1,188 shares during the quarter. Thrivent Financial for Lutherans’ holdings in U.S. Physical Therapy were worth $1,385,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Lazard Asset Management LLC grew its holdings in shares of U.S. Physical Therapy by 754.7% during the 1st quarter. Lazard Asset Management LLC now owns 453 shares of the company’s stock worth $45,000 after purchasing an additional 400 shares during the period. Point72 Hong Kong Ltd purchased a new stake in shares of U.S. Physical Therapy during the 3rd quarter worth about $45,000. Captrust Financial Advisors grew its holdings in shares of U.S. Physical Therapy by 348.9% during the 1st quarter. Captrust Financial Advisors now owns 844 shares of the company’s stock worth $84,000 after purchasing an additional 656 shares during the period. Fifth Third Bancorp grew its holdings in shares of U.S. Physical Therapy by 13.4% during the 4th quarter. Fifth Third Bancorp now owns 916 shares of the company’s stock worth $74,000 after purchasing an additional 108 shares during the period. Finally, Center for Financial Planning Inc. grew its holdings in shares of U.S. Physical Therapy by 3,351.7% during the 4th quarter. Center for Financial Planning Inc. now owns 1,001 shares of the company’s stock worth $81,000 after purchasing an additional 972 shares during the period. Institutional investors and hedge funds own 98.44% of the company’s stock.

Insider Transactions at U.S. Physical Therapy

In other news, EVP Richard Binstein sold 911 shares of the firm’s stock in a transaction that occurred on Thursday, March 2nd. The shares were sold at an average price of $100.78, for a total transaction of $91,810.58. Following the completion of the sale, the executive vice president now owns 9,906 shares of the company’s stock, valued at $998,326.68. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, COO Graham D. Reeve sold 1,912 shares of the firm’s stock in a transaction that occurred on Thursday, March 2nd. The shares were sold at an average price of $100.95, for a total transaction of $193,016.40. Following the completion of the sale, the chief operating officer now owns 8,243 shares of the company’s stock, valued at $832,130.85. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Richard Binstein sold 911 shares of the firm’s stock in a transaction on Thursday, March 2nd. The stock was sold at an average price of $100.78, for a total value of $91,810.58. Following the transaction, the executive vice president now owns 9,906 shares in the company, valued at $998,326.68. The disclosure for this sale can be found here. Over the last quarter, insiders sold 4,814 shares of company stock valued at $484,853. 1.80% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the company. StockNews.com assumed coverage on U.S. Physical Therapy in a report on Thursday. They set a “hold” rating for the company. Barrington Research upped their price target on U.S. Physical Therapy from $110.00 to $116.00 in a report on Friday, May 5th. Finally, TheStreet raised shares of U.S. Physical Therapy from a “c+” rating to a “b-” rating in a research report on Friday, May 5th.

U.S. Physical Therapy Stock Up 1.4 %

Shares of NYSE:USPH opened at $113.87 on Monday. The company has a quick ratio of 1.30, a current ratio of 1.30 and a debt-to-equity ratio of 0.57. U.S. Physical Therapy, Inc. has a 52-week low of $73.30 and a 52-week high of $131.50. The company has a 50 day moving average of $102.86 and a two-hundred day moving average of $94.87. The company has a market capitalization of $1.49 billion, a price-to-earnings ratio of 52.72, a price-to-earnings-growth ratio of 4.34 and a beta of 1.35.

U.S. Physical Therapy (NYSE:USPH – Get Rating) last issued its quarterly earnings data on Wednesday, May 3rd. The company reported $0.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.52 by $0.07. U.S. Physical Therapy had a net margin of 5.40% and a return on equity of 10.93%. The company had revenue of $148.51 million during the quarter, compared to the consensus estimate of $140.77 million. During the same quarter last year, the company earned $0.65 earnings per share. U.S. Physical Therapy’s revenue for the quarter was up 12.8% on a year-over-year basis. As a group, analysts forecast that U.S. Physical Therapy, Inc. will post 2.63 earnings per share for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, June 9th. Stockholders of record on Thursday, May 18th will be given a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.51%. The ex-dividend date is Wednesday, May 17th. U.S. Physical Therapy’s payout ratio is currently 79.63%.

About U.S. Physical Therapy

(Get Rating)

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics, which provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. It operates through the following segments: physical therapy operations and industrial injury prevention services.